Publications by authors named "Michael D Radmacher"

Claim this Profile
P
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.
Heiko Becker, Kati Maharry, Krzysztof Mrózek, Stefano Volinia, Ann-Kathrin Eisfeld, Michael D Radmacher

Leukemia· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.
Zejuan Li, Tobias Herold, Chunjiang He, Peter J M Valk, Ping Chen, Michael D Radmacher

J Clin Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.
Jason H Mendler, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek, Heiko Becker

J Clin Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Ann-Kathrin Eisfeld, Guido Marcucci, Kati Maharry, Sebastian Schwind, Michael D Radmacher

Blood· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia.
Ann-Kathrin Eisfeld, Guido Marcucci, Sandya Liyanarachchi, Konstanze Döhner, Sebastian Schwind, Michael D Radmacher

Proc Natl Acad Sci U S A· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
Zejuan Li, Hao Huang, Yuanyuan Li, Xi Jiang, Ping Chen, Michael D Radmacher

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Guido Marcucci, Klaus H Metzeler, Sebastian Schwind, Heiko Becker, Kati Maharry, Michael D Radmacher

J Clin Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Klaus H Metzeler, Heiko Becker, Kati Maharry, Michael D Radmacher, Jessica Kohlschmidt

Blood· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Heiko Becker, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek, Klaus H Metzeler

Haematologica· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Sebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, Michael D Radmacher, Krzysztof Mrózek

Blood· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Klaus H Metzeler, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek, Dean Margeson

J Clin Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic and functional role of microRNAs in acute myeloid leukemia.
Guido Marcucci, Krzysztof Mrózek, Michael D Radmacher, Ramiro Garzon, Clara D Bloomfield

Blood· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Sebastian Schwind, Guido Marcucci, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek

Blood· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Sebastian Schwind, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek, Kelsi B Holland

J Clin Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Susan P Whitman, Kati Maharry, Michael D Radmacher, Heiko Becker, Krzysztof Mrózek

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Heiko Becker, Guido Marcucci, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek

Blood· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Guido Marcucci, Kati Maharry, Yue-Zhong Wu, Michael D Radmacher, Krzysztof Mrózek

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
Shujun Liu, Lai-Chu Wu, Jiuxia Pang, Ramasamy Santhanam, Sebastian Schwind, Michael D Radmacher

Cancer Cell· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Heiko Becker, Guido Marcucci, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Christian Langer, Guido Marcucci, Kelsi B Holland, Michael D Radmacher, Kati Maharry

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias.
Guido Marcucci, Krzysztof Mrózek, Michael D Radmacher, Clara D Bloomfield, Carlo M Croce

Best Pract Res Clin Haematol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA expression in acute myeloid leukemia.
Guido Marcucci, Michael D Radmacher, Krzysztof Mrózek, Clara D Bloomfield

Curr Hematol Malig Rep· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular signatures in acute myeloid leukemia.
Krzysztof Mrózek, Michael D Radmacher, Clara D Bloomfield, Guido Marcucci

Curr Opin Hematol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.
Guido Marcucci, Kati Maharry, Michael D Radmacher, Krzysztof Mrózek, Tamara Vukosavljevic

J Clin Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.
Jason M Zimmerer, Gregory B Lesinski, Amy S Ruppert, Michael D Radmacher, Carl Noble

Clin Cancer Res· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis